
Trevi Therapeutics edges higher amid takeover speculation

I'm PortAI, I can summarize articles.
Trevi Therapeutics (TRVI) shares rose 1.2% in after-hours trading due to takeover speculation. Traders mentioned a Betaville "uncooked" alert suggesting potential acquisition interest, though the buyer's identity remains unknown.

